EDITORIAL
Published on 23 Aug 2023
Editorial: Translating NK cell scientific research to clinical product manufacturing
doi 10.3389/fimmu.2023.1229417
- 1,587 views
- 1 citation
- Frontiers in Immunology
- NK and Innate Lymphoid Cell Biology
- Research Topics
- Translating NK Cell Scientific Research to Clinical Product Manufacturing
Translating NK Cell Scientific Research to Clinical Product Manufacturing
28k
Total downloads
90k
Total views and downloads
Articles
MINI REVIEW
Published on 08 Jul 2022
iPSCs in NK Cell Manufacturing and NKEV Development
doi 10.3389/fimmu.2022.890894
- 7,033 views
- 8 citations
ORIGINAL RESEARCH
Published on 01 Jun 2022
CAR T Cells Targeting Membrane-Bound Hsp70 on Tumor Cells Mimic Hsp70-Primed NK Cells
doi 10.3389/fimmu.2022.883694
- 4,910 views
- 14 citations
ORIGINAL RESEARCH
Published on 07 Apr 2022
Genetic Engineering and Enrichment of Human NK Cells for CAR-Enhanced Immunotherapy of Hematological Malignancies
doi 10.3389/fimmu.2022.847008
- 10,133 views
- 25 citations
ORIGINAL RESEARCH
Published on 07 Apr 2022
Cryopreserved PM21-Particle-Expanded Natural Killer Cells Maintain Cytotoxicity and Effector Functions In Vitro and In Vivo
doi 10.3389/fimmu.2022.861681
- 8,048 views
- 17 citations
REVIEW
Published on 25 Mar 2022
Innovative Strategies to Improve the Clinical Application of NK Cell-Based Immunotherapy
doi 10.3389/fimmu.2022.859177
- 6,564 views
- 31 citations
REVIEW
Published on 18 Mar 2022
Taking Lessons from CAR-T Cells and Going Beyond: Tailoring Design and Signaling for CAR-NK Cells in Cancer Therapy
doi 10.3389/fimmu.2022.822298
- 7,767 views
- 25 citations
ORIGINAL RESEARCH
Published on 07 Mar 2022
Feeder-Cell-Free and Serum-Free Expansion of Natural Killer Cells Using Cloudz Microspheres, G-Rex6M, and Human Platelet Lysate
doi 10.3389/fimmu.2022.803380
- 12,440 views
- 18 citations
MINI REVIEW
Published on 11 Feb 2022
Feeder Cells at the Interface of Natural Killer Cell Activation, Expansion and Gene Editing
doi 10.3389/fimmu.2022.802906
- 16,061 views
- 27 citations
PERSPECTIVE
Published on 31 Jan 2022
Long-Term Outcome After Adoptive Immunotherapy With Natural Killer Cells: Alloreactive NK Cell Dose Still Matters
doi 10.3389/fimmu.2021.804988
- 2,291 views
- 7 citations
